Lymph node dissection during robot-assisted radical prostatectomy: where do we stand?
Since the initial report of robot-assisted laparoscopic prostatectomy (RALP) in 2001, the technique has gained rapid acceptance and utilization. When compared with more traditional forms of surgical intervention, there is still much debate with respect to cost, and impact on potency and continence. Less often is the focus on oncologic outcomes. Pelvic lymph node dissection (PLND) at the time of prostatectomy is an important part of the surgical intervention for prostate cancer and is currently underreported during robotic procedures. Herein, we review the current controversies on the value and extent of PLND and the status of emerging data regarding robot-assisted PLND.
Silberstein
J L
JL
Department of Surgery, Division of Urology, University of California, San Diego, Medical Center, San Diego, CA 92103-8897, USA. jsilberstein@ucsd.edu
Derweesh
I H
IH
Kane
C J
CJ
D006801:Humans; D010535:Laparoscopy; D008197:Lymph Node Excision / Q000009:adverse effects / Q000379:methods*; D008297:Male; D018579:Patient Selection; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery*; D012371:Robotics / Q000379:methods*